|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation | ALONSO ABAD, Ariel; ONG, Fenny; Stijven, Florian; VAN DER ELST, Wim; MOLENBERGHS, Geert; VAN KEILEGOM, Ingrid; VERBEKE, Geert; Callegaro, Andrea | Journal Contribution | A1 |
| 2 | 2024 | Pairwise fitting of piecewise mixed models for the joint modeling of multivariate longitudinal outcomes, in a randomized crossover trial | MWANGI, Moses; MOLENBERGHS, Geert; Njagi, Edmund Njeru; Mwalili, Samuel; BRAEKERS, Roel; FLOREZ POVEDA, Alvaro; Gachau, Susan; Bukania, Zipporah N.; VERBEKE, Geert | Journal Contribution | A1 |
| 3 | 2023 | Reflections on the concept of optimality of single decision point treatment regimes | Tran, Trung Dung; Abad, Ariel Alonso; VERBEKE, Geert; MOLENBERGHS, Geert; Van Mechelen, Iven | Journal Contribution | A2 |
| 4 | 2023 | Do health beliefs about COVID-19 predict morbidity? A longitudinal study | Delporte, Margaux; De Witte , Dries; Demarest, Stefaan; VERBEKE, Geert; MOLENBERGHS, Geert; Hoorens, Vera | Journal Contribution | A1 |
| 5 | 2023 | Do Optimism and Moralization Predict Vaccination? A Five-Wave Longitudinal Study | Delporte, Margaux; LUYTS, Martial; MOLENBERGHS, Geert; VERBEKE, Geert; Demarest, Stefaan; Hoorens, Vera | Journal Contribution | A1 |
| 6 | 2023 | A longitudinal perspective on perceived vulnerability to disease during the COVID-19 pandemic in Belgium | Delporte, Margaux; De Coninck, David; d'Haenens, Leen; LUYTS, Martial; VERBEKE, Geert; MOLENBERGHS, Geert; Matthijs, Koen | Journal Contribution | A1 |
| 7 | 2023 | Self-uniqueness beliefs and adherence to recommended precautions. A 5-wave longitudinal COVID-19 study | De Witte , Dries; Delporte, Margaux; MOLENBERGHS, Geert; VERBEKE, Geert; Demarest, Stefaan; Hoorens, Vera | Journal Contribution | A1 |
| 8 | 2023 | A longitudinal transition imputation model for categorical data applied to a large registry dataset | Mamouris, Pavlos; NASSIRI, Vahid; VERBEKE, Geert; JANSSENS, Arne; Vaes, Bert; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 9 | 2023 | A joint transition model for evaluating eGFR as biomarker for rejection after kidney transplantation | Coemans, Maarten; VERBEKE, Geert; Naesens, Maarten | Journal Contribution | A1 |
| 10 | 2023 | A combined overdispersed longitudinal model for nominal data | Sercundes, Ricardo K.; MOLENBERGHS, Geert; VERBEKE, Geert; Demetrio, Clarice G. B.; da Silva, Sila C.; Moral, Rafael A. | Journal Contribution | A1 |
| 11 | 2023 | Evaluation of a flexible piecewise linear mixed-effects model in the analysis of randomized cross-over trials | MWANGI, Moses; VERBEKE, Geert; Njagi, Edmund Njeru; Florez, Alvaro Jose; Mwalili, Samuel; IVANOVA, Anna; Bukania, Zipporah N.; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 12 | 2023 | A joint normal-binary (probit) model for high-dimensional longitudinal data | Delporte, Margaux; FIEUWS, Steffen; MOLENBERGHS, Geert; VERBEKE, Geert; De Coninck, David; Hoorens, Vera | Journal Contribution | A1 |
| 13 | 2023 | A multivariate spatio-temporal model for the incidence of imported COVID-19 cases and COVID-19 deaths in Cuba | De Witte , Dries; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VERBEKE, Geert; SANCHEZ, Lizet; Mas-Bermejo, Pedro; NEYENS, Thomas | Journal Contribution | A1 |
| 14 | 2023 | A linear mixed model to estimate COVID-19-induced excess mortality | VERBEECK, Johan; FAES, Christel; NEYENS, Thomas; HENS, Niel; VERBEKE, Geert; Deboosere, Patrick; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 15 | 2023 | Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK | Conrad, Nathalie; Misra, Shivani; Verbakel, Jan Y.; VERBEKE, Geert; MOLENBERGHS, Geert; Taylor, Peter N.; Mason, Justin; Sattar, Naveed; McMurray, John J. V.; McInnes, Iain B.; Khunti, Kamlesh; Cambridge, Geraldine | Journal Contribution | A1 |
| 16 | 2022 | Bias by censoring for competing events in survival analysis | Coemans, Maarten; VERBEKE, Geert; Doehler, Bernd; Suesal, Caner; Naesens, Maarten | Journal Contribution | A1 |
| 17 | 2022 | Bayesian model selection for multilevel mediation models | Ariyo, Oludare; LESAFFRE, Emmanuel; VERBEKE, Geert; Huisman, Martijn; Heymans, Martijn; Twisk, Jos | Journal Contribution | A1 |
| 18 | 2022 | Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK | Conrad, Nathalie; VERBEKE, Geert; MOLENBERGHS, Geert; Goetschalckx, Laura; Callender, Thomas; Cambridge, Geraldine; Mason, Justin C.; Rahimi, Kazem; McMurray, John J., V; Verbakel, Jan Y. | Journal Contribution | A1 |
| 19 | 2022 | Estimating COVID-19-Related Excess Mortality Excluding Seasonal Phenomena in Belgium | VERBEECK, Johan; FAJGENBLAT, Maxime; WILLEM, Lander; NEYENS, Thomas; FAES, Christel; HENS, Niel; Deboosere, Patrick; VERBEKE, Geert; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 20 | 2022 | A copula-based approach to joint modelling of multiple longitudinal responses with multimodal structures | Mahdiyeh, Zahra; Kazemi, Iraj; VERBEKE, Geert | Journal Contribution | A1 |
| 21 | 2022 | A joint normal-binary (probit) model | Delporte, Margaux; FIEUWS, Steffen; MOLENBERGHS, Geert; VERBEKE, Geert; Wanyama, Simeon Situma; Hatziagorou, Elpis; De Boeck, Christiane | Journal Contribution | A1 |
| 22 | 2022 | Implementing the meta-analytic approach for the evaluation of surrogate endpoints in SAS and R: a word of caution | ONG, Fenny; Wang, Jingzhao; VAN DER ELST, Wim; VERBEKE, Geert; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 23 | 2022 | Optimal weighted estimation versus Cochran–Mantel–Haenszel | HERMANS, Lisa; MOLENBERGHS, Geert; VERBEKE, Geert; Kenward, Michael G.; Mamouris, Pavlos; Vaes, Bart | Journal Contribution | A1 |
| 24 | 2021 | Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens” | Liesenborghs, Laurens; Spriet, Isabel; Jochmans, Dirk; Belmans, Ann; Gyselinck, Iwein; Teuwen, Laure-Anne; ter Horst, Sebastiaan; Geukens, Tatjana; Engelen, Matthias M.; Landeloos, Ewout; Geldhof, Vincent; Ceunen, Helga; Debaveye, Barbara; Linden, Lorenz Van der; JACOBS, Sofie; Boudewijns, Robbert; Do, Thuc Nguyen Dan; Chiu, Winston; Weynand, Birgit; Vanassche, Thomas; Meyfroidt, Geert; JANSSENS, Wim; Vos, Robin; Vermeersch, Pieter; Wauters, Joost; VERBEKE, Geert; Kaptein, Suzanne J. F.; Rocha-Pereira, Joana; Van Wijngaerden, Eric; Neyts, Johan; Verhamme, Peter; Dreesen, Erwin; Vandenberk, Bert; Zhang, Xin; Wang, Xinyu; Devos, Timothy; De Munter, Paul; Delang, Leen; Langendries, Lana | Journal Contribution | A1 |
| 25 | 2021 | Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial | Gyselinck, I; Liesenborgs , L; Landeloos, E; Belmans, A; VERBEKE, Geert; Verhamme, P; VOS, R; Janssens , W | Journal Contribution | A1 |
| 26 | 2021 | Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-ofconcept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial | Gyselinck, Iwein; Liesenborghs, Laurens; Landeloos, Ewout; Belmans , Ann; VERBEKE, Geert; Verhamme, Peter; Vos, Robin; JANSSENS, Wim | Journal Contribution | M |
Loading...
5
0
5
0
false